Title: Effectiveness and Safety of Short Course Liposomal Amphotericin B (AmBisome) as First Line Treatment for Visceral Leishmaniasis in Bangladesh
Author: Emiliano Lucero
Institution: Institute of Tropical Medicine and International Health, Berlin
Graduate date: 2015-04-29 (W3C-DTF)
Document: Lucero_Abstract.pdf
Bangladesh is one of the endemic countries for Visceral Leishmaniasis (VL). MSF ran a VL treatment clinic in the most endemic district (Fulbaria) between 2010 and 2013 using a semi-ambulatory regimen for primary VL of 15mg per kg Liposomal Amphotericin-B (AmBisome) in three equal doses of 5mg per kg. The main objective of this study was to analyze the effectiveness and safety of this regimen after a 12 month follow up period by retrospective analysis of routinely collected program data. A secondary objective was to explore risk factors for relapse.
Classification: 2015 (LCSH)
Language: English
Date Of Record Creation: 2015-05-06 06:22:35 (W3C-DTF)
Date Of Record Release: 2015-05-06 13:08:51 (W3C-DTF)
Date Last Modified: 2015-05-06 13:14:46 (W3C-DTF)

Report a Problem with this Resource Record

Log In: